Cargando…
Effect of Metformin on Different Non-Diabetes Related Conditions, a Special Focus on Malignant Conditions: Review of Literature
Metformin has been proven to be one of the most safe and effective antihyperglycemic agents. Through more than six decades of metformin use, it became the most studied hypoglycemic agent; through these studies, it showed a marvelous non-glycemic related effect. These effects include modulation of di...
Autores principales: | Abdelgadir, Elamin, Ali, Razan, Rashid, Fauzia, Bashier, Alaaeldin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elmer Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5380171/ https://www.ncbi.nlm.nih.gov/pubmed/28392858 http://dx.doi.org/10.14740/jocmr2922e |
Ejemplares similares
-
SGLT-2 Inhibitors and Cardiovascular Protection: Lessons and Gaps in Understanding the Current Outcome Trials and Possible Benefits of Combining SGLT-2 Inhibitors With GLP-1 Agonists
por: Abdelgadir, Elamin, et al.
Publicado: (2018) -
Efficacy and Safety of SGLT2 Inhibitors in Reducing Glycated Hemoglobin and Weight in Emirati Patients With Type 2 Diabetes
por: Bashier, Alaaeldin, et al.
Publicado: (2017) -
Lipid Control in Patients with Diabetes across Primary and Tertiary Government Health Sectors in Dubai: A Five-year Pattern
por: Abdelgadir, Elamin, et al.
Publicado: (2019) -
Glycemic Control in Patients with Diabetes across Primary and Tertiary Government Health Sectors in the Emirate of Dubai, United Arab Emirates: A Five-Year Pattern
por: Alawadi, Fatheya, et al.
Publicado: (2019) -
Consensus recommendations for management of patients with type 2 diabetes mellitus and cardiovascular diseases
por: Bashier, Alaaeldin, et al.
Publicado: (2019)